Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients

Similar Items

• Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib
  od: Press, Richard D., i dr.
  Izdano: (2009)
• BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib
  od: Sherbenou, Daniel W., i dr.
  Izdano: (2010)
• Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
  od: Elias, Marjanu Hikmah, i dr.
  Izdano: (2012)
• Novel mutations in the RING-finger domain of BRCA1 gene in clinically diagnosed breast cancer patients
  od: Kumar, Pasupuleti Santhosh, i dr.
  Izdano: (2020)
• BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib
  od: Benjamin, Esther Sathya Bama, i dr.
  Izdano: (2021)